| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 107 | 2024 | 380 | 13.880 |
Why?
|
| Puerto Rico | 159 | 2024 | 1378 | 6.530 |
Why?
|
| Mental Disorders | 42 | 2022 | 309 | 6.200 |
Why?
|
| Child | 174 | 2024 | 3131 | 5.020 |
Why?
|
| Adolescent | 191 | 2024 | 5363 | 4.810 |
Why?
|
| Alcohol-Related Disorders | 6 | 2019 | 55 | 2.800 |
Why?
|
| Alcohol Drinking | 11 | 2023 | 519 | 2.790 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 22 | 2019 | 98 | 2.620 |
Why?
|
| Anti-Asthmatic Agents | 11 | 2020 | 31 | 2.620 |
Why?
|
| Male | 176 | 2024 | 20025 | 2.560 |
Why?
|
| Depression | 14 | 2020 | 712 | 2.550 |
Why?
|
| Female | 180 | 2024 | 20969 | 2.540 |
Why?
|
| Substance-Related Disorders | 18 | 2024 | 730 | 2.460 |
Why?
|
| Humans | 239 | 2024 | 37093 | 2.460 |
Why?
|
| Parents | 19 | 2023 | 329 | 2.420 |
Why?
|
| Depressive Disorder, Major | 12 | 2024 | 103 | 2.380 |
Why?
|
| Child, Preschool | 61 | 2024 | 1418 | 2.350 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 14 | 2020 | 282 | 2.320 |
Why?
|
| Prevalence | 46 | 2023 | 1455 | 2.060 |
Why?
|
| Mental Health Services | 14 | 2022 | 118 | 1.930 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 8 | 2020 | 53 | 1.800 |
Why?
|
| Young Adult | 54 | 2024 | 4268 | 1.770 |
Why?
|
| Child Abuse | 11 | 2020 | 79 | 1.730 |
Why?
|
| Longitudinal Studies | 35 | 2023 | 885 | 1.660 |
Why?
|
| Disasters | 4 | 2015 | 65 | 1.630 |
Why?
|
| Culture | 13 | 2017 | 173 | 1.610 |
Why?
|
| Alcoholism | 5 | 2019 | 240 | 1.610 |
Why?
|
| Family Health | 3 | 2017 | 56 | 1.590 |
Why?
|
| Adult | 77 | 2024 | 11712 | 1.570 |
Why?
|
| Social Support | 7 | 2019 | 394 | 1.560 |
Why?
|
| Antisocial Personality Disorder | 8 | 2021 | 17 | 1.560 |
Why?
|
| Cyclonic Storms | 5 | 2022 | 64 | 1.530 |
Why?
|
| Stress, Psychological | 17 | 2024 | 583 | 1.520 |
Why?
|
| Residence Characteristics | 9 | 2024 | 322 | 1.470 |
Why?
|
| Sex Factors | 20 | 2021 | 898 | 1.380 |
Why?
|
| New York City | 29 | 2024 | 220 | 1.370 |
Why?
|
| Genome-Wide Association Study | 18 | 2022 | 333 | 1.310 |
Why?
|
| Cross-Cultural Comparison | 16 | 2016 | 107 | 1.300 |
Why?
|
| Parent-Child Relations | 7 | 2019 | 110 | 1.300 |
Why?
|
| Anxiety Disorders | 13 | 2017 | 309 | 1.280 |
Why?
|
| Adolescent Behavior | 10 | 2019 | 253 | 1.220 |
Why?
|
| Social Environment | 12 | 2019 | 207 | 1.170 |
Why?
|
| Poverty | 10 | 2024 | 348 | 1.080 |
Why?
|
| Family | 5 | 2020 | 173 | 1.070 |
Why?
|
| Hypersensitivity | 7 | 2020 | 30 | 1.070 |
Why?
|
| Socioeconomic Factors | 18 | 2018 | 1067 | 1.040 |
Why?
|
| Life Change Events | 5 | 2022 | 92 | 1.010 |
Why?
|
| Violence | 10 | 2023 | 134 | 1.010 |
Why?
|
| Anxiety | 9 | 2019 | 754 | 1.000 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2016 | 864 | 1.000 |
Why?
|
| Acculturation | 10 | 2019 | 188 | 0.990 |
Why?
|
| Middle Aged | 38 | 2021 | 10129 | 0.980 |
Why?
|
| Mental Health | 11 | 2024 | 303 | 0.970 |
Why?
|
| Rhode Island | 12 | 2015 | 16 | 0.960 |
Why?
|
| Medication Adherence | 4 | 2014 | 179 | 0.940 |
Why?
|
| Health Services Accessibility | 6 | 2014 | 560 | 0.920 |
Why?
|
| Risk Factors | 38 | 2022 | 3562 | 0.900 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2014 | 253 | 0.890 |
Why?
|
| Suicide, Attempted | 6 | 2021 | 91 | 0.880 |
Why?
|
| Child of Impaired Parents | 5 | 2023 | 18 | 0.880 |
Why?
|
| Logistic Models | 20 | 2019 | 923 | 0.850 |
Why?
|
| Health Surveys | 11 | 2012 | 373 | 0.840 |
Why?
|
| DNA Methylation | 11 | 2023 | 325 | 0.830 |
Why?
|
| Depressive Disorder | 8 | 2017 | 174 | 0.820 |
Why?
|
| Psychometrics | 11 | 2013 | 318 | 0.820 |
Why?
|
| Child Behavior Disorders | 3 | 2011 | 35 | 0.800 |
Why?
|
| Comorbidity | 18 | 2019 | 623 | 0.800 |
Why?
|
| Allergens | 8 | 2020 | 63 | 0.790 |
Why?
|
| Healthcare Disparities | 3 | 2012 | 494 | 0.790 |
Why?
|
| Nasal Mucosa | 5 | 2023 | 29 | 0.770 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2022 | 767 | 0.760 |
Why?
|
| Conduct Disorder | 5 | 2017 | 49 | 0.740 |
Why?
|
| Cross-Sectional Studies | 23 | 2022 | 2721 | 0.730 |
Why?
|
| United States | 33 | 2021 | 4223 | 0.730 |
Why?
|
| Parenting | 6 | 2023 | 127 | 0.720 |
Why?
|
| Immunoglobulin E | 12 | 2023 | 55 | 0.720 |
Why?
|
| Quality of Life | 8 | 2022 | 481 | 0.710 |
Why?
|
| Health Education | 2 | 2016 | 338 | 0.700 |
Why?
|
| Family Relations | 2 | 2018 | 46 | 0.700 |
Why?
|
| Primary Health Care | 4 | 2016 | 294 | 0.680 |
Why?
|
| Twins | 3 | 2015 | 17 | 0.680 |
Why?
|
| Juvenile Delinquency | 3 | 2019 | 44 | 0.670 |
Why?
|
| Severity of Illness Index | 16 | 2018 | 610 | 0.650 |
Why?
|
| Child Health Services | 3 | 2011 | 43 | 0.640 |
Why?
|
| Prospective Studies | 17 | 2024 | 1378 | 0.640 |
Why?
|
| Protestantism | 1 | 2018 | 5 | 0.630 |
Why?
|
| Sex Offenses | 2 | 2022 | 37 | 0.620 |
Why?
|
| Vitamin D Deficiency | 5 | 2018 | 105 | 0.610 |
Why?
|
| Somatoform Disorders | 2 | 2009 | 16 | 0.590 |
Why?
|
| Interviews as Topic | 10 | 2012 | 381 | 0.590 |
Why?
|
| Social Control, Informal | 1 | 2016 | 9 | 0.580 |
Why?
|
| Attitude | 1 | 2018 | 104 | 0.570 |
Why?
|
| Temperament | 2 | 2015 | 31 | 0.570 |
Why?
|
| Social Problems | 1 | 2016 | 14 | 0.570 |
Why?
|
| Urban Population | 5 | 2010 | 333 | 0.560 |
Why?
|
| Case-Control Studies | 18 | 2020 | 1130 | 0.560 |
Why?
|
| Bronchodilator Agents | 6 | 2022 | 25 | 0.540 |
Why?
|
| Self Care | 2 | 2016 | 159 | 0.540 |
Why?
|
| Employment | 1 | 2016 | 76 | 0.520 |
Why?
|
| Internal-External Control | 3 | 2011 | 53 | 0.520 |
Why?
|
| Anxiety, Separation | 1 | 2015 | 4 | 0.520 |
Why?
|
| Smoking | 6 | 2013 | 940 | 0.500 |
Why?
|
| Case Management | 1 | 2014 | 20 | 0.500 |
Why?
|
| Vital Capacity | 7 | 2022 | 39 | 0.500 |
Why?
|
| Patient Education as Topic | 3 | 2016 | 215 | 0.480 |
Why?
|
| Obesity | 8 | 2022 | 1067 | 0.480 |
Why?
|
| Caregivers | 7 | 2014 | 182 | 0.470 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2023 | 389 | 0.470 |
Why?
|
| Interview, Psychological | 9 | 2013 | 61 | 0.470 |
Why?
|
| Social Adjustment | 3 | 2011 | 30 | 0.470 |
Why?
|
| Medicaid | 2 | 2016 | 109 | 0.460 |
Why?
|
| Age Factors | 10 | 2020 | 1033 | 0.460 |
Why?
|
| Complementary Therapies | 1 | 2014 | 46 | 0.460 |
Why?
|
| New York | 7 | 2020 | 71 | 0.450 |
Why?
|
| Hospitalization | 3 | 2020 | 388 | 0.430 |
Why?
|
| Odds Ratio | 11 | 2019 | 534 | 0.430 |
Why?
|
| Multivariate Analysis | 11 | 2016 | 583 | 0.410 |
Why?
|
| Insurance, Health | 3 | 2021 | 126 | 0.410 |
Why?
|
| Respiratory Function Tests | 7 | 2022 | 55 | 0.400 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 974 | 0.400 |
Why?
|
| Lung | 7 | 2022 | 446 | 0.400 |
Why?
|
| Peer Group | 1 | 2013 | 156 | 0.390 |
Why?
|
| Infant | 7 | 2021 | 1046 | 0.390 |
Why?
|
| Sibling Relations | 1 | 2011 | 1 | 0.390 |
Why?
|
| Achievement | 1 | 2011 | 24 | 0.380 |
Why?
|
| Leukocytes | 4 | 2020 | 72 | 0.380 |
Why?
|
| Adaptation, Psychological | 4 | 2016 | 385 | 0.380 |
Why?
|
| Air Pollution | 3 | 2020 | 60 | 0.370 |
Why?
|
| Chronic Disease | 4 | 2012 | 484 | 0.370 |
Why?
|
| Sick Role | 1 | 2010 | 6 | 0.370 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2023 | 53 | 0.370 |
Why?
|
| Family Conflict | 1 | 2010 | 11 | 0.370 |
Why?
|
| Antigens, Dermatophagoides | 3 | 2020 | 8 | 0.360 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 208 | 0.360 |
Why?
|
| Health Services Needs and Demand | 2 | 2010 | 146 | 0.360 |
Why?
|
| Transients and Migrants | 3 | 2009 | 39 | 0.360 |
Why?
|
| Rhinitis | 2 | 2020 | 16 | 0.360 |
Why?
|
| Patient Selection | 1 | 2011 | 164 | 0.360 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2020 | 11 | 0.350 |
Why?
|
| Health Status Disparities | 4 | 2012 | 642 | 0.350 |
Why?
|
| Environmental Exposure | 4 | 2020 | 216 | 0.350 |
Why?
|
| Sexual Behavior | 4 | 2022 | 609 | 0.340 |
Why?
|
| Cohort Studies | 12 | 2024 | 1492 | 0.340 |
Why?
|
| Overweight | 2 | 2022 | 247 | 0.340 |
Why?
|
| Forced Expiratory Volume | 5 | 2022 | 70 | 0.340 |
Why?
|
| Cultural Diversity | 5 | 2007 | 169 | 0.340 |
Why?
|
| Resilience, Psychological | 2 | 2024 | 66 | 0.330 |
Why?
|
| Drug Therapy | 1 | 2008 | 17 | 0.320 |
Why?
|
| Morbidity | 3 | 2011 | 91 | 0.320 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 161 | 0.320 |
Why?
|
| Perception | 1 | 2010 | 195 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2009 | 138 | 0.310 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 219 | 0.310 |
Why?
|
| Personality Assessment | 6 | 2011 | 42 | 0.310 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 31 | 0.310 |
Why?
|
| Psychophysiologic Disorders | 2 | 2010 | 5 | 0.310 |
Why?
|
| Air Pollution, Indoor | 2 | 2020 | 41 | 0.300 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 32 | 0.290 |
Why?
|
| Minority Groups | 7 | 2022 | 596 | 0.290 |
Why?
|
| Dominican Republic | 5 | 2014 | 20 | 0.290 |
Why?
|
| Research Design | 3 | 2017 | 313 | 0.290 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2018 | 162 | 0.280 |
Why?
|
| Genomics | 2 | 2019 | 223 | 0.280 |
Why?
|
| Stress, Physiological | 2 | 2020 | 150 | 0.280 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 935 | 0.280 |
Why?
|
| Diet | 4 | 2023 | 801 | 0.280 |
Why?
|
| Community-Based Participatory Research | 1 | 2010 | 317 | 0.270 |
Why?
|
| Child Reactive Disorders | 1 | 2005 | 3 | 0.270 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 5 | 0.270 |
Why?
|
| Emigration and Immigration | 5 | 2011 | 82 | 0.260 |
Why?
|
| Treatment Outcome | 8 | 2020 | 1369 | 0.260 |
Why?
|
| Dust | 3 | 2014 | 54 | 0.260 |
Why?
|
| Research | 1 | 2006 | 163 | 0.250 |
Why?
|
| Vitamin D | 6 | 2022 | 196 | 0.250 |
Why?
|
| Utilization Review | 3 | 2006 | 14 | 0.250 |
Why?
|
| Child Behavior | 2 | 2019 | 78 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 628 | 0.240 |
Why?
|
| Emigrants and Immigrants | 2 | 2021 | 137 | 0.240 |
Why?
|
| Genotype | 4 | 2020 | 730 | 0.240 |
Why?
|
| Age of Onset | 3 | 2011 | 100 | 0.230 |
Why?
|
| Health Literacy | 3 | 2023 | 105 | 0.230 |
Why?
|
| Health Services | 2 | 2016 | 57 | 0.230 |
Why?
|
| Interleukin-13 | 1 | 2023 | 19 | 0.230 |
Why?
|
| Disease Progression | 5 | 2023 | 601 | 0.230 |
Why?
|
| Fossil Fuels | 1 | 2023 | 1 | 0.230 |
Why?
|
| Tobacco Use Disorder | 1 | 2007 | 237 | 0.230 |
Why?
|
| Sampling Studies | 5 | 2006 | 61 | 0.220 |
Why?
|
| Pregnancy | 5 | 2021 | 1549 | 0.220 |
Why?
|
| Sensation | 3 | 2020 | 35 | 0.220 |
Why?
|
| Risk-Taking | 2 | 2017 | 451 | 0.220 |
Why?
|
| Th2 Cells | 2 | 2023 | 58 | 0.210 |
Why?
|
| Aged | 14 | 2014 | 6741 | 0.210 |
Why?
|
| Adolescent Health Services | 1 | 2002 | 29 | 0.210 |
Why?
|
| Social Behavior | 2 | 2018 | 131 | 0.210 |
Why?
|
| Incidence | 6 | 2023 | 922 | 0.200 |
Why?
|
| Crime Victims | 1 | 2022 | 77 | 0.200 |
Why?
|
| Time Factors | 4 | 2014 | 1742 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2002 | 404 | 0.200 |
Why?
|
| Cannabis | 1 | 2023 | 79 | 0.200 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2020 | 48 | 0.190 |
Why?
|
| Cultural Competency | 2 | 2014 | 131 | 0.190 |
Why?
|
| Cultural Characteristics | 3 | 2011 | 125 | 0.190 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 140 | 0.190 |
Why?
|
| Social Values | 2 | 2011 | 30 | 0.190 |
Why?
|
| Nerve Net | 1 | 2021 | 76 | 0.190 |
Why?
|
| Vehicle Emissions | 1 | 2020 | 23 | 0.180 |
Why?
|
| CpG Islands | 5 | 2020 | 97 | 0.180 |
Why?
|
| Puberty | 1 | 2020 | 25 | 0.180 |
Why?
|
| Testosterone | 1 | 2021 | 193 | 0.180 |
Why?
|
| Sulfur Dioxide | 1 | 2019 | 6 | 0.180 |
Why?
|
| Qualitative Research | 2 | 2013 | 446 | 0.180 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 43 | 0.180 |
Why?
|
| Spirometry | 2 | 2010 | 33 | 0.180 |
Why?
|
| Gambling | 1 | 2019 | 15 | 0.180 |
Why?
|
| Criminals | 1 | 2019 | 15 | 0.180 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 17 | 0.180 |
Why?
|
| Unemployment | 3 | 2016 | 23 | 0.170 |
Why?
|
| Cytokines | 3 | 2018 | 602 | 0.170 |
Why?
|
| Mexico | 4 | 2008 | 240 | 0.170 |
Why?
|
| Air Pollutants | 1 | 2020 | 94 | 0.170 |
Why?
|
| Adolescent Development | 1 | 2019 | 31 | 0.170 |
Why?
|
| Homosexuality | 1 | 2019 | 36 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 75 | 0.170 |
Why?
|
| Sexual Partners | 1 | 2022 | 314 | 0.170 |
Why?
|
| Estradiol | 1 | 2021 | 262 | 0.170 |
Why?
|
| Cuba | 3 | 2008 | 32 | 0.170 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 77 | 0.170 |
Why?
|
| Interleukin-17 | 2 | 2017 | 53 | 0.170 |
Why?
|
| Heterosexuality | 1 | 2019 | 88 | 0.160 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 2 | 2015 | 4 | 0.160 |
Why?
|
| Affective Symptoms | 2 | 2011 | 57 | 0.160 |
Why?
|
| Human Development | 1 | 2018 | 8 | 0.160 |
Why?
|
| Law Enforcement | 1 | 2018 | 14 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 481 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 1015 | 0.160 |
Why?
|
| Interleukin-5 Receptor alpha Subunit | 1 | 2017 | 1 | 0.150 |
Why?
|
| Albuterol | 2 | 2015 | 9 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2016 | 400 | 0.150 |
Why?
|
| Population | 1 | 2017 | 10 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2023 | 426 | 0.150 |
Why?
|
| Statistics as Topic | 4 | 2016 | 117 | 0.150 |
Why?
|
| Cockroaches | 1 | 2017 | 7 | 0.150 |
Why?
|
| Genome, Human | 2 | 2017 | 135 | 0.150 |
Why?
|
| Epithelium | 3 | 2023 | 79 | 0.150 |
Why?
|
| Tropical Climate | 1 | 2017 | 20 | 0.150 |
Why?
|
| Focus Groups | 4 | 2013 | 348 | 0.150 |
Why?
|
| Airway Resistance | 1 | 2017 | 7 | 0.150 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 49 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 664 | 0.150 |
Why?
|
| Language | 3 | 2008 | 157 | 0.140 |
Why?
|
| Maternal Exposure | 1 | 2017 | 33 | 0.140 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 26 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 191 | 0.140 |
Why?
|
| Headache | 3 | 2012 | 19 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2017 | 99 | 0.140 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 626 | 0.140 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 225 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2016 | 6 | 0.140 |
Why?
|
| Attitude to Health | 2 | 2018 | 325 | 0.140 |
Why?
|
| Preventive Health Services | 1 | 2016 | 64 | 0.140 |
Why?
|
| Firearms | 1 | 2016 | 16 | 0.130 |
Why?
|
| Inservice Training | 1 | 2016 | 33 | 0.130 |
Why?
|
| Schools | 1 | 2017 | 260 | 0.130 |
Why?
|
| Counseling | 1 | 2016 | 116 | 0.130 |
Why?
|
| Nurses | 1 | 2016 | 48 | 0.130 |
Why?
|
| Weapons | 1 | 2015 | 5 | 0.130 |
Why?
|
| Body Mass Index | 5 | 2022 | 854 | 0.130 |
Why?
|
| Psychiatry | 2 | 2007 | 27 | 0.130 |
Why?
|
| World Health Organization | 2 | 2013 | 31 | 0.130 |
Why?
|
| Administration, Inhalation | 4 | 2017 | 80 | 0.130 |
Why?
|
| Sulfites | 1 | 2015 | 6 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2015 | 26 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2016 | 170 | 0.130 |
Why?
|
| Genetic Markers | 3 | 2023 | 142 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2024 | 2026 | 0.120 |
Why?
|
| Disability Evaluation | 2 | 2013 | 61 | 0.120 |
Why?
|
| Community Health Services | 1 | 2016 | 185 | 0.120 |
Why?
|
| Androstadienes | 1 | 2014 | 18 | 0.120 |
Why?
|
| Cyclopropanes | 1 | 2014 | 40 | 0.120 |
Why?
|
| Acetates | 1 | 2014 | 21 | 0.120 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 5 | 0.120 |
Why?
|
| Demography | 4 | 2007 | 175 | 0.120 |
Why?
|
| Models, Biological | 1 | 2017 | 677 | 0.120 |
Why?
|
| Linear Models | 4 | 2015 | 275 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2014 | 98 | 0.120 |
Why?
|
| Physicians | 1 | 2016 | 163 | 0.120 |
Why?
|
| Abdominal Pain | 2 | 2012 | 24 | 0.120 |
Why?
|
| Sulfides | 1 | 2014 | 62 | 0.120 |
Why?
|
| Quinolines | 1 | 2014 | 64 | 0.110 |
Why?
|
| Object Attachment | 2 | 2011 | 24 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 227 | 0.110 |
Why?
|
| Fungi | 1 | 2014 | 89 | 0.110 |
Why?
|
| Disabled Children | 1 | 2013 | 9 | 0.110 |
Why?
|
| Friends | 1 | 2013 | 22 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 191 | 0.110 |
Why?
|
| Breast Feeding | 1 | 2014 | 113 | 0.110 |
Why?
|
| Models, Psychological | 2 | 2017 | 131 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2020 | 753 | 0.110 |
Why?
|
| Eosinophils | 2 | 2023 | 20 | 0.110 |
Why?
|
| Premature Birth | 1 | 2013 | 75 | 0.110 |
Why?
|
| Delivery of Health Care | 2 | 2012 | 276 | 0.100 |
Why?
|
| Adiposity | 1 | 2013 | 154 | 0.100 |
Why?
|
| Population Groups | 2 | 2009 | 56 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 97 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2015 | 454 | 0.100 |
Why?
|
| Skin Tests | 3 | 2016 | 14 | 0.100 |
Why?
|
| Boston | 1 | 2010 | 22 | 0.100 |
Why?
|
| Prescriptions | 1 | 2010 | 18 | 0.090 |
Why?
|
| Social Perception | 1 | 2011 | 62 | 0.090 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2008 | 25 | 0.090 |
Why?
|
| Risk | 1 | 2011 | 267 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2011 | 65 | 0.090 |
Why?
|
| Prejudice | 1 | 2011 | 110 | 0.090 |
Why?
|
| Psychopathology | 2 | 2020 | 15 | 0.090 |
Why?
|
| Migraine Disorders | 1 | 2010 | 7 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2013 | 387 | 0.090 |
Why?
|
| Psychomotor Agitation | 1 | 2010 | 6 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 94 | 0.090 |
Why?
|
| Brain | 1 | 2018 | 1346 | 0.090 |
Why?
|
| Maternal Welfare | 1 | 2009 | 7 | 0.090 |
Why?
|
| Impulsive Behavior | 1 | 2010 | 46 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 71 | 0.090 |
Why?
|
| Regression Analysis | 3 | 2019 | 455 | 0.080 |
Why?
|
| Capacity Building | 1 | 2010 | 87 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 212 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2009 | 84 | 0.080 |
Why?
|
| Health Status | 1 | 2012 | 380 | 0.080 |
Why?
|
| Phenotype | 3 | 2020 | 689 | 0.080 |
Why?
|
| Forecasting | 1 | 2009 | 128 | 0.080 |
Why?
|
| Attention | 1 | 2010 | 156 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2013 | 550 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2010 | 339 | 0.080 |
Why?
|
| Crack Cocaine | 2 | 2004 | 8 | 0.080 |
Why?
|
| Endotoxins | 2 | 2020 | 18 | 0.080 |
Why?
|
| Self Efficacy | 2 | 2009 | 184 | 0.080 |
Why?
|
| Heroin Dependence | 2 | 2004 | 23 | 0.080 |
Why?
|
| Sweden | 2 | 2017 | 12 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 217 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2023 | 681 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 2 | 2004 | 85 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2007 | 48 | 0.070 |
Why?
|
| Community Health Planning | 1 | 2006 | 35 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 61 | 0.070 |
Why?
|
| Dissociative Disorders | 1 | 2006 | 10 | 0.070 |
Why?
|
| Data Collection | 2 | 2008 | 194 | 0.070 |
Why?
|
| Siblings | 1 | 2006 | 18 | 0.070 |
Why?
|
| Mothers | 1 | 2008 | 181 | 0.070 |
Why?
|
| Syndrome | 1 | 2005 | 74 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 21 | 0.070 |
Why?
|
| Program Development | 1 | 2006 | 233 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 2379 | 0.060 |
Why?
|
| Public Health | 2 | 2024 | 372 | 0.060 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2004 | 18 | 0.060 |
Why?
|
| Hospital Bed Capacity | 1 | 2024 | 5 | 0.060 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 30 | 0.060 |
Why?
|
| Environment | 1 | 2005 | 138 | 0.060 |
Why?
|
| Rural Population | 1 | 2006 | 294 | 0.060 |
Why?
|
| Urban Health | 1 | 2004 | 95 | 0.060 |
Why?
|
| Phobic Disorders | 1 | 2004 | 25 | 0.060 |
Why?
|
| Hospitals | 1 | 2024 | 86 | 0.060 |
Why?
|
| Nose | 1 | 2023 | 15 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 205 | 0.060 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 121 | 0.060 |
Why?
|
| Registries | 2 | 2017 | 335 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 400 | 0.050 |
Why?
|
| Axonemal Dyneins | 1 | 2022 | 6 | 0.050 |
Why?
|
| Residential Treatment | 1 | 2002 | 7 | 0.050 |
Why?
|
| Hospitals, Psychiatric | 1 | 2002 | 14 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2002 | 42 | 0.050 |
Why?
|
| Animals | 5 | 2018 | 15081 | 0.050 |
Why?
|
| Rest | 1 | 2021 | 26 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 146 | 0.050 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2021 | 20 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 174 | 0.050 |
Why?
|
| Brazil | 1 | 2021 | 64 | 0.050 |
Why?
|
| Medically Uninsured | 1 | 2021 | 56 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2021 | 51 | 0.050 |
Why?
|
| HLA-D Antigens | 1 | 2020 | 1 | 0.050 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 6 | 0.050 |
Why?
|
| Progesterone | 1 | 2021 | 113 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2021 | 100 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 195 | 0.050 |
Why?
|
| Child Day Care Centers | 1 | 2020 | 11 | 0.050 |
Why?
|
| Family Therapy | 1 | 1980 | 21 | 0.050 |
Why?
|
| Mexican Americans | 1 | 2022 | 189 | 0.050 |
Why?
|
| Twins, Dizygotic | 2 | 2013 | 8 | 0.050 |
Why?
|
| Twins, Monozygotic | 2 | 2013 | 8 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2020 | 195 | 0.040 |
Why?
|
| Costa Rica | 1 | 2019 | 7 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 10 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2023 | 646 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 43 | 0.040 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2019 | 5 | 0.040 |
Why?
|
| Lectins | 1 | 2019 | 20 | 0.040 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Sleep | 1 | 2021 | 152 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 111 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 121 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2019 | 172 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 65 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 515 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2014 | 894 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2017 | 10 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 539 | 0.040 |
Why?
|
| International Cooperation | 1 | 2017 | 46 | 0.040 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2017 | 2 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2021 | 517 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 85 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 41 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 25 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 293 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 325 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2020 | 384 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2017 | 180 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Folic Acid | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 13 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 441 | 0.030 |
Why?
|
| Dairy Products | 1 | 2015 | 35 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 33 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 238 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2015 | 9 | 0.030 |
Why?
|
| Transportation | 1 | 2014 | 26 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2014 | 4 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 44 | 0.030 |
Why?
|
| Telephone | 1 | 2014 | 34 | 0.030 |
Why?
|
| Models, Economic | 1 | 2014 | 20 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 187 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 147 | 0.030 |
Why?
|
| Educational Status | 2 | 2007 | 313 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 34 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 173 | 0.030 |
Why?
|
| Translating | 2 | 2004 | 16 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 61 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 972 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 144 | 0.030 |
Why?
|
| Rwanda | 1 | 2013 | 1 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2013 | 89 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 305 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 64 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 435 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2013 | 129 | 0.030 |
Why?
|
| Proteins | 1 | 2015 | 369 | 0.030 |
Why?
|
| Self Concept | 1 | 2013 | 154 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 5913 | 0.030 |
Why?
|
| Cities | 1 | 2012 | 63 | 0.030 |
Why?
|
| Medical Records | 1 | 2012 | 41 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2012 | 136 | 0.030 |
Why?
|
| Father-Child Relations | 1 | 2011 | 12 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 215 | 0.020 |
Why?
|
| Emotions | 1 | 2013 | 220 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 465 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 59 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 2010 | 5 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1207 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 247 | 0.020 |
Why?
|
| Pregnancy Trimesters | 1 | 2009 | 14 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 58 | 0.020 |
Why?
|
| Language Tests | 1 | 2008 | 22 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2008 | 19 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2008 | 59 | 0.020 |
Why?
|
| Connecticut | 1 | 2007 | 14 | 0.020 |
Why?
|
| Social Conditions | 1 | 2007 | 12 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 36 | 0.020 |
Why?
|
| Latin America | 1 | 2006 | 45 | 0.020 |
Why?
|
| Multilingualism | 1 | 2007 | 46 | 0.020 |
Why?
|
| Income | 1 | 2007 | 140 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2006 | 117 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 613 | 0.020 |
Why?
|
| Mass Screening | 1 | 2008 | 462 | 0.010 |
Why?
|
| Domestic Violence | 1 | 2004 | 30 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 16 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2004 | 94 | 0.010 |
Why?
|
| Cognition | 1 | 2007 | 398 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2003 | 76 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 203 | 0.010 |
Why?
|
| Family Characteristics | 1 | 1980 | 108 | 0.010 |
Why?
|